1 |
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China [J]. N Engl J Med, 2020, 382(18): 1708-1720.
|
2 |
Xiao F, Tang M, Zheng X, et al. Evidence for gastrointestinal infection of SARS-CoV-2 [J]. Gastroenterology, 2020, 158(6): 1831-1833.
|
3 |
Aroniadis OC, Dimaio CJ, Dixon RE, et al. Current knowledge and research priorities in the digestive manifestations of COVID-19 [J]. Clin Gastroenterol Hepatol, 2020, 18(8): 1682-1684.
|
4 |
O'Brien CM, Jung K, Dang W, et al. Collateral damage: the impact of the COVID-19 pandemic on acute abdominal emergency presentations [J]. J Am Coll Radiol, 2020, 17(11): 1443-1449.
|
5 |
Mao R, Qiu Y, He JS, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis [J]. Lancet Gastroenterol Hepatol, 2020, 5(7): 667-678.
|
6 |
Wang F, Wang H, Fan J, et al. Pancreatic injury patterns in patients with coronavirus disease 19 pneumonia [J]. Gastroenterology, 2020, 159(1): 367-370.
|
7 |
Liu F, Long X, Zhang B, et al. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection [J]. Clin Gastroenterol Hepatol, 2020, 18(9): 2128-2130.
|
8 |
McNabb-Baltar J, Jin DX, Grover AS, et al. Lipase elevation in patients with COVID-19 [J]. Am J Gastroenterol, 2020, 115(8): 1286-1288.
|
9 |
Bruno G, Fabrizio C, Santoro CR, et al. Pancreatic injury in the course of coronavirus disease 2019: a not-so-rare occurrence [J]. J Med Virol, 2021, 93(1): 74-75.
|
10 |
Barlass U, Wiliams B, Dhana K, et al. Marked elevation of lipase in COVID-19 disease: a cohort study [J]. Clin Transl Gastroenterol, 2020, 11(7): e215.
|
11 |
Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus [J]. Gut, 2013, 62(1): 102-111.
|
12 |
Stephens JR, Wong J, Broomhead R, et al. Raised serum amylase in patients with COVID-19 may not be associated with pancreatitis [J]. Br J Surg, 2021, 108(4):e152-e153.
|
13 |
Wang K, Luo J, Tan F, et al. Acute pancreatitis as the initial manifestation in 2 cases of COVID-19 in Wuhan, China [J]. Open Forum Infect Dis, 2020, 7(9): a324.
|
14 |
Alloway BC, Yaeger SK, Mazzaccaro RJ, et al. Suspected case of COVID-19-associated pancreatitis in a child [J]. Radiol Case Rep, 2020, 15(8): 1309-1312.
|
15 |
Miao Y, Lidove O, Mauhin W. First case of acute pancreatitis related to SARS-CoV-2 infection [J]. Br J Surg, 2020, 107(8): e270.
|
16 |
Anand ER, Major C, Pickering O, et al. Acute pancreatitis in a COVID-19 patient [J]. Br J Surg, 2020, 107(7): e182.
|
17 |
Kumaran NK, Karmakar BK, Taylor OM. Coronavirus disease-19 (COVID-19) associated with acute necrotising pancreatitis (ANP) [J]. BMJ Case Rep, 2020, 13(9): e237903.
|
18 |
Elhence A, Mahapatra SJ, Vajpai T, et al. Acute pancreatitis and nosocomial COVID-19: cause specific host responses may determine lung injury [J]. Pancreatology, 2020, 20(7): 1258-1261.
|
19 |
Hadi A, Werge M, Kristiansen KT, et al. Coronavirus disease-19 (COVID-19) associated with severe acute pancreatitis: case report on three family members [J]. Pancreatology, 2020, 20(4): 665-667.
|
20 |
Aloysius MM, Thatti A, Gupta A, et al. COVID-19 presenting as acute pancreatitis [J]. Pancreatology, 2020, 20(5): 1026-1027.
|
21 |
Schepis T, Larghi A, Papa A, et al. SARS-CoV2 RNA detection in a pancreatic pseudocyst sample [J]. Pancreatology, 2020, 20(5): 1011-1012.
|
22 |
姚小红, 李廷源, 何志承, 等. 新型冠状病毒肺炎(COVID-19)三例遗体多部位穿刺组织病理学研究 [J]. 中华病理学杂志, 2020, 49(5): 411-417.
|
23 |
Lax SF, Skok K, Zechner P, et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome : results from a prospective, single-center, clinicopathologic case series [J]. Ann Intern Med, 2020, 173(5): 350-361.
|
24 |
Hanley B, Naresh KN, Roufosse C, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study [J]. Lancet Microbe, 2020, 1(6): e245-e253.
|
25 |
Gubatan J, Levitte S, Patel A, et al. Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California [J]. Gut, 2021, 70(2): 440-441.
|
26 |
Bonney GK, Gao Y, Chew CA, et al. SARS-COV-2 associated acute pancreatitis: cause, consequence or epiphenomenon? [J]. Pancreatology, 2020, 20(5): 1017-1018.
|
27 |
Inamdar S, Benias PC, Liu Y, et al. Prevalence, risk factors, and outcomes of hospitalized patients with coronavirus disease 2019 presenting as acute pancreatitis [J]. Gastroenterology, 2020, 159(6): 2226-2228.
|
28 |
Dirweesh A, Li Y, Trikudanathan G, et al. Clinical outcomes of acute pancreatitis in patients with coronavirus disease 2019 [J]. Gastroenterology, 2020, 159(5): 1972-1974.
|
29 |
Pandanaboyana S, Moir J, Leeds JS, al et; COVID PAN collaborative group. SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study [J]. Gut, 2021, 70(6): 1061-1069.
|
30 |
Rawla P, Bandaru SS, Vellipuram AR. Review of infectious etiology of acute pancreatitis [J]. Gastroenterol Res, 2017, 10(3): 153-158.
|
31 |
Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor [J]. Cell, 2020, 181(2): 271-280.
|
32 |
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin [J]. Nature, 2020, 579(7798): 270-273.
|
33 |
Liu F, Long X, Zhang B, et al. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection [J]. Clin Gastroenterol Hepatol, 2020, 18(9): 2128-2130.
|
34 |
Li H, Liu L, Zhang D, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses [J]. Lancet, 2020, 395(10235): 1517-1520.
|
35 |
El-Kurdi B, Khatua B, Rood C, et al. Mortality from coronavirus disease 2019 increases with unsaturated fat and may be reduced by early calcium and albumin supplementation [J]. Gastroenterology, 2020, 159(3): 1015-1018.
|
36 |
Hegyi P, Szakacs Z, Sahin-Toth M. Lipotoxicity and cytokine storm in severe acute pancreatitis and COVID-19 [J]. Gastroenterology, 2020, 159(3): 824-827.
|
37 |
黄东亚, 苗毅, 蒋奎荣, 等. 重症患者伴高淀粉酶和/或高脂肪酶血症: 急性胰腺炎? [J/OL]. 中华重症医学电子杂志, 2017, 3(2): 138-142.
|
38 |
De-Madaria E, Siau K, Cardenas-Jaen K. Increased amylase and lipase in patients with COVID-19 pneumonia: don't blame the pancreas just yet! [J]. Gastroenterology, 2020, S0016-5085(20): 30561-30568.
|
39 |
Ashok A, Faghih M, Singh VK. Mild pancreatic enzyme elevations in COVID-19 pneumonia: synonymous with injury or noise? [J]. Gastroenterology, 2020, S0016-5085(20): 34778.
|
40 |
Mukherjee R, Smith A, Sutton R. Covid-19-related pancreatic injury [J]. Br J Surg, 2020, 107(7): e190.
|
41 |
Goyal H, Sachdeva S, Perisetti A, et al. Hyperlipasemia and potential pancreatic injury patterns in COVID-19: a marker of severity or innocent bystander? [J]. Gastroenterology, 2021, 160(3): 946-948.
|
42 |
Cerda-Contreras C, Nuzzolo-Shihadeh L, Camacho-Ortiz A, et al. Baricitinib as treatment for COVID-19: friend or foe of the pancreas? [J]. Clin Infect Dis, 2020: online ahead of print.
|
43 |
Khadka S, Williams K, Solanki S. "Remdesivir-Associated Pancreatitis" [J]. Am J Ther, 2021. Epub ahead of print.
|
44 |
Morrison AR, Johnson JM, Ramesh M, et al. Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab [J]. J Med Virol, 2020, 92(10): 1791-1792.
|
45 |
Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19 [J]. N Engl J Med, 2020, 382(19): 1787-1799.
|
46 |
Ng SC, Tilg H. COVID-19 and the gastrointestinal tract: more than meets the eye [J]. Gut, 2020, 69(6): 973-974.
|
47 |
Coccolini F, Tartaglia D, Puglisi A, et al. SARS-CoV-2 is present in peritoneal fluid in COVID-19 patients [J]. Ann Surg, 2020, 272(3): e240.
|
48 |
Stahel PF. How to risk-stratify elective surgery during the COVID-19 pandemic? [J]. Patient Saf Surg, 2020, 14: 8.
|
49 |
Zhou J, Li C, Liu X, et al. Infection of bat and human intestinal organoids by SARS-CoV-2 [J]. Nat Med, 2020, 26(7): 1077-1083.
|